碳离子放疗与光子放疗治疗Ⅰ期食管癌的剂量学比较。
Dosimetric Comparison Between Carbon-ion Radiotherapy and Photon Radiotherapy for Stage I Esophageal Cancer.
机构信息
Department of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Japan;
Department of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Japan.
出版信息
In Vivo. 2021 Jan-Feb;35(1):447-452. doi: 10.21873/invivo.12277.
Abstract
BACKGROUND/AIM: The present study aimed to compare the radiation dose distribution of carbon-ion radiotherapy (CIRT) for stage I esophageal cancer with three-dimensional conformal radiotherapy (3DCRT) and volumetric modulated arc therapy (VMAT).
PATIENTS AND METHODS
Fifteen patients with cT1bN0M0 esophageal cancer who received 3DCRT at Kanagawa Cancer Center between January 2014 and April 2019 were enrolled. The dose-volume histogram parameters of the target volume and normal organs planned with CIRT, 3DCRT, and VMAT were evaluated.
RESULTS
The homogeneity index for the target volume of CIRT was significantly lower than that of 3DCRT and VMAT. In addition, the radiation dose of CIRT to the heart, lungs, spinal cord, and skin was significantly lower than that of 3DCRT and VMAT.
CONCLUSION
Favorable dose distributions with CIRT were demonstrated compared with 3DCRT and VMAT for esophageal cancer.
摘要
背景/目的：本研究旨在比较碳离子放疗（CIRT）与三维适形放疗（3DCRT）和容积旋转调强放疗（VMAT）治疗 I 期食管癌的剂量分布。
患者和方法
本研究纳入了 2014 年 1 月至 2019 年 4 月在神奈川癌症中心接受 3DCRT 治疗的 15 例 cT1bN0M0 食管癌患者。评估了 CIRT、3DCRT 和 VMAT 计划的靶区和正常器官的剂量-体积直方图参数。
结果
CIRT 靶区的均匀性指数明显低于 3DCRT 和 VMAT。此外，CIRT 对心脏、肺、脊髓和皮肤的辐射剂量明显低于 3DCRT 和 VMAT。
结论
与 3DCRT 和 VMAT 相比，CIRT 治疗食管癌可获得更好的剂量分布。
相似文献
1
Dosimetric Comparison Between Carbon-ion Radiotherapy and Photon Radiotherapy for Stage I Esophageal Cancer.
In Vivo. 2021 Jan-Feb;35(1):447-452. doi: 10.21873/invivo.12277.
2
Dosimetric Comparison of Radiation Therapy Using Hybrid-VMAT Technique for Stage I Esophageal Cancer.
Anticancer Res. 2021 Apr;41(4):1951-1958. doi: 10.21873/anticanres.14962.
3
Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma.
Acta Oncol. 2018 Dec;57(12):1713-1720. doi: 10.1080/0284186X.2018.1502467. Epub 2018 Sep 28.
4
A Dosimetric Comparative Study of Carbon-Ion Radiotherapy Versus X-ray Volumetric Modulated Arc Therapy for Stage III Non-Small-Cell Lung Cancer.
Niger J Clin Pract. 2024 Feb 1;27(2):236-243. doi: 10.4103/njcp.njcp_734_23. Epub 2024 Feb 26.
5
Dosimetric comparison of 3-dimensional conformal radiotherapy, volumetric modulated arc therapy, and helical tomotherapy for postoperative gastric cancer patients.
Jpn J Radiol. 2018 Jan;36(1):30-39. doi: 10.1007/s11604-017-0696-x. Epub 2017 Nov 3.
6
Association of volumetric-modulated arc therapy with radiation pneumonitis in thoracic esophageal cancer.
J Radiat Res. 2022 Jul 19;63(4):646-656. doi: 10.1093/jrr/rrac021.
7
[Dosimetric comparison of the helical tomotherapy, intensity-modulated radiotherapy and volumetric-modulated arc therapy in radical radiotherapy for esophageal cancer].
Zhonghua Yi Xue Za Zhi. 2019 Nov 5;99(41):3260-3265. doi: 10.3760/cma.j.issn.0376-2491.2019.41.012.
8
Dosimetric and efficiency comparison of high-dose radiotherapy for esophageal cancer: volumetric modulated arc therapy versus fixed-field intensity-modulated radiotherapy.
Dis Esophagus. 2014 Aug;27(6):585-90. doi: 10.1111/dote.12144. Epub 2013 Oct 18.
9
Radiation therapy of synchronous bilateral breast carcinoma (SBBC) using multiple techniques.
Med Dosim. 2018;43(1):55-68. doi: 10.1016/j.meddos.2017.08.003. Epub 2017 Oct 5.
10
Dosimetric comparison between step-shoot intensity-modulated radiotherapy and volumetric-modulated arc therapy for upper thoracic and cervical esophageal carcinoma.
Med Dosim. 2016 Summer;41(2):131-5. doi: 10.1016/j.meddos.2015.10.007. Epub 2016 Feb 23.
引用本文的文献
1
Current status and prospect of particle therapy for esophageal cancer.
Precis Radiat Oncol. 2024 Jun 27;8(2):92-98. doi: 10.1002/pro6.1232. eCollection 2024 Jun.
2
Outcomes of definitive carbon-ion radiotherapy for cT1bN0M0 esophageal squamous cell carcinoma.
Esophagus. 2024 Oct;21(4):523-529. doi: 10.1007/s10388-024-01067-7. Epub 2024 May 30.
3
Dosimetric rationale and preliminary experience in proton plus carbon-ion radiotherapy for esophageal carcinoma: a retrospective analysis.
Radiat Oncol. 2023 Dec 1;18(1):195. doi: 10.1186/s13014-023-02371-9.
4
Planning strategies for robust carbon-ion scanning radiotherapy for stage I esophageal cancer: a retrospective study.
J Radiat Res. 2023 Sep 22;64(5):816-823. doi: 10.1093/jrr/rrad057.
5
A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute.
Cancers (Basel). 2022 Apr 18;14(8):2033. doi: 10.3390/cancers14082033.
本文引用的文献
1
Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer.
Radiat Oncol. 2020 May 27;15(1):127. doi: 10.1186/s13014-020-01575-7.
2
The Ion-Beam Radiation Oncology Center in Kanagawa (i-ROCK) Carbon Ion Facility at the Kanagawa Cancer Center.
Int J Part Ther. 2016 Winter;2(3):478-480. doi: 10.14338/IJPT-15-00024.1. Epub 2016 Feb 9.
3
Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies.
J Appl Clin Med Phys. 2019 Jul;20(7):15-27. doi: 10.1002/acm2.12623. Epub 2019 May 21.
4
Radiation Pneumonitis after Intensity-Modulated Radiotherapy for Esophageal Cancer: Institutional Data and a Systematic Review.
Sci Rep. 2019 Feb 19;9(1):2255. doi: 10.1038/s41598-018-38414-5.
5
Multi-institutional Study of Carbon-ion Radiotherapy for Locally Advanced Pancreatic Cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1403 Pancreas.
Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1212-1221. doi: 10.1016/j.ijrobp.2018.04.057. Epub 2018 May 1.
6
Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.
Radiat Oncol. 2018 Feb 9;13(1):23. doi: 10.1186/s13014-018-0966-5.
7
Predictive factors of acute skin reactions to carbon ion radiotherapy for the treatment of malignant bone and soft tissue tumors.
Radiat Oncol. 2017 Nov 22;12(1):185. doi: 10.1186/s13014-017-0927-4.
8
Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.
Radiother Oncol. 2017 Oct;125(1):48-54. doi: 10.1016/j.radonc.2017.07.034. Epub 2017 Sep 13.
9
Multicenter Study of Carbon-Ion Radiation Therapy for Mucosal Melanoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN).
Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):1054-1060. doi: 10.1016/j.ijrobp.2016.12.028. Epub 2016 Dec 26.
10
A multi-institutional analysis of prospective studies of carbon ion radiotherapy for prostate cancer: A report from the Japan Carbon ion Radiation Oncology Study Group (J-CROS).
Radiother Oncol. 2016 Nov;121(2):288-293. doi: 10.1016/j.radonc.2016.10.009. Epub 2016 Nov 9.
Zotero 插件